POSA269 Above and Beyond: Assessing the Nature and Impact of Additional Considerations Above Clinical and Cost Effectiveness by 8 HTA Agencies for a Rare Disease Area
Jan 1, 2022, 00:00 AM
10.1016/j.jval.2021.11.836
https://www.valueinhealthjournal.com/article/S1098-3015(21)02631-0/fulltext
Section Title :
Section Order :
10365
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02631-0&doi=10.1016/j.jval.2021.11.836